APA (7th ed.) Citation

Gassert, F., Rübenthaler, J., Cyran, C. C., Rink, J., Schwarze, V., Luitjens, J., . . . Froelich, M. F. (2021). 18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: A primary economic evaluation. European journal of nuclear medicine and molecular imaging, 48(10), . https://doi.org/10.1007/s00259-021-05193-7

Chicago Style (17th ed.) Citation

Gassert, Felix, et al. "18F FDG PET/MRI with Hepatocyte-specific Contrast Agent for M Staging of Rectal Cancer: A Primary Economic Evaluation." European Journal of Nuclear Medicine and Molecular Imaging 48, no. 10 (2021). https://doi.org/10.1007/s00259-021-05193-7.

MLA (9th ed.) Citation

Gassert, Felix, et al. "18F FDG PET/MRI with Hepatocyte-specific Contrast Agent for M Staging of Rectal Cancer: A Primary Economic Evaluation." European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 10, 2021, https://doi.org/10.1007/s00259-021-05193-7.